Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PharmaMar's Yondelis completes requirements for launch in Spain

Dec. 31, 2007

Endocyte and R&D-Biopharmaceuticals enter tubulysin chemo agent agreement

Dec. 31, 2007

Cell Therapeutics completes Zevalin's acquisition for U.S. sales and marketing

Dec. 31, 2007

Phase I trial commences for Cougar Biotechnology's CB-3304

Dec. 31, 2007

Progen's phase III study of PI-88 for HCC open for recruitment

Dec. 31, 2007

Phase II IPI-504 trial initiated in patients with non-small cell lung cancer

Dec. 28, 2007

Peregrine gives update on its three lead clinical programs for bavituximab and Cotara

Dec. 28, 2007

Tissue-specific FAK gene deletion blocks mammary tumor progression

Dec. 28, 2007

Preliminary phase I results with AT-9283 in hematological malignancies encouraging

Dec. 28, 2007

Activity seen with SNS-595 in acute leukemia patients

Dec. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...